Form 8-K - Current report:
SEC Accession No. 0001493152-25-012316
Filing Date
2025-08-26
Accepted
2025-08-26 07:30:22
Documents
15
Period of Report
2025-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44996
2 EX-1.1 ex1-1.htm EX-1.1 351785
3 EX-99.1 ex99-1.htm EX-99.1 14380
4 GRAPHIC ex99-1_001.jpg GRAPHIC 16617
  Complete submission text file 0001493152-25-012316.txt   672447

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE curx-20250825.xsd EX-101.SCH 3065
6 XBRL LABEL FILE curx-20250825_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE curx-20250825_pre.xml EX-101.PRE 22392
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3894
Mailing Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753
Business Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753 718-673-6078
Curanex Pharmaceuticals Inc (Filer) CIK: 0002025942 (see all company filings)

EIN.: 830741390 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42815 | Film No.: 251252619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)